StockData
Coya Therapeutics, Inc. logo

Coya Therapeutics, Inc. (COYA) stock

COYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/3016% above fair value
$2.95−0.03 (-1.01%)

Close on Nov 20, 2026Market cap $69.20MP/E –Yield –

Coya Therapeutics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

No free cash flow figures for Coya Therapeutics

Coya Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Coya Therapeutics figures

See a number that looks wrong?